"DNA Adducts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The products of chemical reactions that result in the addition of extraneous chemical groups to DNA.
| Descriptor ID |
D018736
|
| MeSH Number(s) |
D13.444.308.135 G05.200.104
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA Adducts".
Below are MeSH descriptors whose meaning is more specific than "DNA Adducts".
This graph shows the total number of publications written about "DNA Adducts" by people in this website by year, and whether "DNA Adducts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Adducts" by people in Profiles.
-
Curcumin inhibits PhIP induced cytotoxicity in breast epithelial cells through multiple molecular targets. Cancer Lett. 2015 Aug 28; 365(1):122-31.
-
Myeloperoxidase-induced genomic DNA-centered radicals. J Biol Chem. 2010 Jun 25; 285(26):20062-71.
-
The crystal structures of psoralen cross-linked DNAs: drug-dependent formation of Holliday junctions. J Mol Biol. 2001 Apr 20; 308(1):15-26.
-
Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Mol Pharmacol. 1999 May; 55(5):938-47.
-
Binding of nuclear proteins associated with mammalian DNA repair to the mitomycin C-DNA interstrand crosslink. Environ Mol Mutagen. 1998; 31(1):70-81.
-
Removal of O6-methylguanine from plant DNA in vivo is accelerated under conditions of clastogenic adaptation. Environ Mol Mutagen. 1997; 29(4):400-5.
-
Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin. Biochim Biophys Acta. 1996 Jun 07; 1307(2):213-9.